FORA Capital LLC Purchases New Position in Henry Schein, Inc. $HSIC

Key Points

• FORA Capital LLC purchased 11,455 shares of Henry Schein, Inc., valued at approximately $785,000, indicating a growing interest from institutional investors.
• Henry Schein's stock has experienced fluctuations, recently trading at $68.98 with a 52-week range of $60.56 to $82.49.
• The company reported $1.10 earnings per share for the last quarter, missing estimates, while revenue increased by 3.3% year-over-year.

FORA Capital LLC bought a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 11,455 shares of the company's stock, valued at approximately $785,000.

Several other large investors have also added to or reduced their stakes in the business. JPMorgan Chase & Co. boosted its holdings in Henry Schein by 6.5% during the first quarter. JPMorgan Chase & Co. now owns 6,373,036 shares of the company's stock worth $436,489,000 after purchasing an additional 390,399 shares during the last quarter. Palestra Capital Management LLC acquired a new position in Henry Schein during the fourth quarter worth $182,988,000. Dimensional Fund Advisors LP boosted its holdings in Henry Schein by 4.8% during the first quarter. Dimensional Fund Advisors LP now owns 2,240,933 shares of the company's stock worth $153,480,000 after purchasing an additional 103,384 shares during the last quarter. Burgundy Asset Management Ltd. boosted its holdings in Henry Schein by 33.9% during the first quarter. Burgundy Asset Management Ltd. now owns 2,235,429 shares of the company's stock worth $153,105,000 after purchasing an additional 566,530 shares during the last quarter. Finally, Clarkston Capital Partners LLC boosted its holdings in Henry Schein by 0.4% during the first quarter. Clarkston Capital Partners LLC now owns 1,751,570 shares of the company's stock worth $119,965,000 after purchasing an additional 7,345 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on HSIC shares. UBS Group reduced their target price on shares of Henry Schein from $75.00 to $70.00 and set a "neutral" rating for the company in a report on Wednesday, August 6th. Baird R W cut shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a research note on Monday, July 14th. Leerink Partners set a $75.00 price target on shares of Henry Schein in a research note on Monday, July 14th. Wells Fargo & Company cut their price target on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 6th. Finally, Barrington Research cut their price target on shares of Henry Schein from $86.00 to $78.00 and set an "outperform" rating for the company in a research note on Wednesday, August 6th. Five research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $76.67.

Henry Schein Price Performance

HSIC stock traded up $0.55 during mid-day trading on Monday, hitting $69.58. The stock had a trading volume of 1,021,767 shares, compared to its average volume of 2,089,105. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49. The firm has a market capitalization of $8.44 billion, a P/E ratio of 22.45, a P/E/G ratio of 2.30 and a beta of 0.86. The firm has a fifty day simple moving average of $70.35 and a 200 day simple moving average of $69.98.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The firm had revenue of $3.24 billion during the quarter, compared to the consensus estimate of $3.22 billion. During the same period in the prior year, the business earned $1.23 earnings per share. Henry Schein's quarterly revenue was up 3.3% compared to the same quarter last year. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. As a group, research analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.